Welcome to the European Association for Cancer Research
Connecting cancer researchers together
The Systemic Consequences of Cancer: Cancer as a Whole-body Disease
Virtual Event : 25 - 26 February 2025
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Opening words: Marcus Goncalves
Session 1: Tumour and Host Metabolism
Session Chair: Marcus Goncalves
Ayelet Erez Weizmann Institute of Science, Rehovot, Israel
'Deciphering the metabolic complexity of tumor-host interactions to improve diagnosis and therapy'
Q&A 13:25-13:35
Dimitrios Anastasiou The Francis Crick Institute, London, UK
'Roles of host metabolism in liver cancer'
Q&A 13:55-14:05
Lorenza Bodo Molecular Biotechnology Center "Guido Tarone", Torino, Italy
Proffered Paper 1: 'Impaired cAMP/CREB1 signaling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia'
Q&A 14:15-14:20
FLASH TALKS - Session 1
5 abstracts presented as 3-minute flash talks
REFRESHMENT BREAK
Session 2: Cachexia and Anorexia
Session Chair: Eileen White
Tobias Janowitz Cold Spring Harbor Laboratory, New York, USA
'Interorgan Communication in Cancer Cachexia'
Q&A 15:15-15-25
Hannah Garner McGill University, Montreal, Canada
Proffered Paper 2: 'Understanding how breast tumours hijack myelopoiesis to promote immunosuppression and disease progression'
Q&A 15:35-15:40
POSTER SPOTLIGHTS
3 top-scoring abstracts each presented as a 5 minute talk with 5 minutes Q&A
Danna Breen Pfizer, Cambridge, USA
'Revitalizing Hope: Ponsegromab's (anti-GDF-15) Potential for Breakthrough Targeted Treatment for Cancer Cachexia'
Q&A 16:30-16:40
FLASH TALKS - Session 2
4 abstracts presented as 3-minute flash talks
END OF DAY 1
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
Session 3: The Metastatic Niche
Session Chair: Tobias Janowitz
Thales Papagiannakopoulos NYU Langone Health, New York, USA
'A dietary switch promotes cancer-associated cachexia in lung cancer'
Q&A 14:25-14:35
FLASH TALKS - Session 3
5 abstracts presented as 3-minute flash talks
Manuel Valiente CNIO, Madrid, Spain
'The brain metastatic niche as a source of systemic vulnerabilities and opportunities'
Q&A 15:15-15:25
Anabel Eckerling Tel Aviv University, Tel Aviv, Israel
Proffered Paper 3: 'Sympathetic regulation of tumor secretome and anti-tumor immunity: Perioperative blockade of β-adrenergic and prostaglandin signaling limits metastatic progression'
Q&A 15:35 - 15:40
REFRESHMENT BREAK
Session 4: Cancer Modulating Immune Response
Session Chair: Eileen White
Ye'ela Scharff Tel Aviv University, Tel Aviv, Israel
Proffered Paper 4: 'Complement signaling is a hallmark of inflammatory fibroblasts in chronic diseases and cancer'
Q&A 16:05-16:10
Adrian Hayday Crick Institute, London, UK
'Bringing cancer immunotherapy to more cancers and to many more people'
Q&A 16:30 - 16:40
KEYNOTE LECTURE
William Kaelin Dana-Farber Cancer Institute, Boston, USA
'Roles of HIF2 and PTHLH in Kidney Cancer-Associated Cachexia: Treatment with a First-In-Class Agent'
Q&A 17:00-17:15
DISCUSSION SESSION
Eileen White (Rutgers Cancer Institute of New Jersey, New Jersey, USA); Karen Vousden (Crick Institute, London, UK); Marcus Goncalves (Weill Cornell Medicine, New York, USA); Tobias Janowitz (Cold Spring Harbor Laboratory, New York, USA)
SUMMARY AND CLOSE
